Medical News

---

• CTPA rules out PE in high-risk patients
• Type 1 lesions found in a minority of ischemic stroke patients
• Efalizumab effective for psoriasis after failed TNF blocker therapy
• Prostate cancer radiation dose predicts disease-free survival
• Suboptimal health behaviors among prostate cancer survivors
• <i>HER2</i>, <i>TOP2A</i> status does not predict positive response to anthracyclines
• Prostate cancer radiation dose predicts disease-free survival
• Suboptimal health behaviors among prostate cancer survivors
• Pitavastatin may have non-cholesterol lowering benefits
• HDL cholesterol effect of several genes linked with carbohydrate intake
• Hyperinsulinemia best predictor of Type 2 diabetes and dysglycemia
• Metformin improves cardiometabolic risk factors in prediabetes
• ‘Substantial proportion’ of PCI patients readmitted within 30 days
• Out-of-home employment lowers CHD risk in middle-aged women
• <i>HER2</i>, <i>TOP2A</i> status does not predict positive response to anthracyclines

CTPA rules out PE in high-risk patients Posted: 27 Aug 2009 05:00 PM PDT Computed tomography pulmonary angiography can rule out pulmonary embolism in patients with a high pretest probability of thrombosis and/or positive D-dimer test, show the results of a meta-analysis published in the Journal of Thrombosis and Haemostasis.

Type 1 lesions found in a minority of ischemic stroke patients Posted: 27 Aug 2009 05:00 PM PDT The so-called "classical" diffusion and perfusion imaging patterns in acute ischemic stroke are present in less than 30% of patients, research indicates.

Efalizumab effective for psoriasis after failed TNF blocker therapy Posted: 27 Aug 2009 05:00 PM PDT Efalizumab can be used to treat psoriasis in patients who have either failed to respond adequately to tumor necrosis factor blockers or been unable to tolerate them, say researchers/show study results.

Prostate cancer radiation dose predicts disease-free survival Posted: 27 Aug 2009 05:00 PM PDT The dose of radiation given to intermediate-risk prostate cancer patients is the most significant factor for predicting freedom from biochemical failure rates 10 years after treatment, study findings suggest.

Suboptimal health behaviors among prostate cancer survivors Posted: 27 Aug 2009 05:00 PM PDT Survivors of cancer, including prostate cancer, have suboptimal health behaviors, say US researchers who also found that physical activity and healthy diet have a positive impact on quality of life, while obesity has a negative impact.

<i>HER2</i>, <i>TOP2A</i> status does not predict positive response to anthracyclines Posted: 27 Aug 2009 05:00 PM PDT Copy number alterations in the genes encoding human epidermal growth factor receptor and topoisomerase II α are not associated with positive outcome in women with early-stage breast cancer treated with doxorubicin and cyclophosphamide, say researchers.

Prostate cancer radiation dose predicts disease-free survival Posted: 27 Aug 2009 05:00 PM PDT The dose of radiation given to intermediate-risk prostate cancer patients is the most significant factor for predicting freedom from biochemical failure rates 10 years after treatment, study findings suggest.

Suboptimal health behaviors among prostate cancer survivors Posted: 27 Aug 2009 05:00 PM PDT Survivors of cancer, including prostate cancer, have suboptimal health behaviors, say US researchers who also found that physical activity and healthy diet have a positive impact on quality of life, while obesity has a negative impact.

Pitavastatin may have non-cholesterol lowering benefits Posted: 27 Aug 2009 05:00 PM PDT Pitavastatin may inhibit the progression of atherosclerosis by promoting improvements in chemokines and platelet activation markers that are dependent on adiponectin, Japanese research suggests.

HDL cholesterol effect of several genes linked with carbohydrate intake Posted: 27 Aug 2009 05:00 PM PDT The impact of several genes on high-density lipoprotein cholesterol concentrations may be affected by carbohydrate intake, a US study suggests.

Hyperinsulinemia best predictor of Type 2 diabetes and dysglycemia Posted: 27 Aug 2009 05:00 PM PDT Hyperinsulinemia at baseline was the most effective predictor of future Type 2 diabetes or dysglycemia, show results from a 24-year follow-up study.

Metformin improves cardiometabolic risk factors in prediabetes Posted: 27 Aug 2009 05:00 PM PDT In people at high risk for developing diabetes, the use of metformin shows beneficial effects on cardiometabolic risk factors, post-hoc analysis shows.

‘Substantial proportion’ of PCI patients readmitted within 30 days Posted: 27 Aug 2009 05:00 PM PDT Around one in seven Medicare patients who undergo percutaneous coronary intervention are readmitted within 30 days of the procedure and these individuals are almost six times more likely to die at this time than their peers who remain out of hospital, study findings show.

Out-of-home employment lowers CHD risk in middle-aged women Posted: 27 Aug 2009 05:00 PM PDT Middle-aged women employed outside of the home have around a 30% lower risk for coronary heart disease than homemakers, results of community-based study show.

<i>HER2</i>, <i>TOP2A</i> status does not predict positive response to anthracyclines Posted: 27 Aug 2009 05:00 PM PDT Copy number alterations in the genes encoding human epidermal growth factor receptor and topoisomerase II α are not associated with positive outcome in women with early-stage breast cancer treated with doxorubicin and cyclophosphamide, say researchers.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610